Latest round: Post IPO equity. Markus Warmuth is the President and CEO of Monte Rosa Therapeutics. Based in Boston, Massachusetts.
Markus Warmuth is the President and CEO of Monte Rosa Therapeutics. He recently sold 8,000 shares of common stock, which is his largest open-market disposition since January 2026, though a previous sale in January was larger. Following this transaction, he retains 605,471 directly held common shares.
Full founder directory · Investor directory · Company funding database · Fundraising library